Join Resmed at the ERS congress 2026 | Resmed UK

Together, let’s help more patients stay on therapy

Your partner in the journey to sleep and breathing health

Long-term adherence remains a major challenge in the management of obstructive sleep apnoea (OSA), chronic obstructive pulmonary disease (COPD) and obesity hypoventilation syndrome (OHS).

OSA

1 in 4 patients discontinue CPAP within the first year1

COPD

1 in 3 patients discontinue home NIV within the first year2 *

OHS

Up to 1 in 2 patients discontinue home NIV within the first year3 **

At ERS 2026, explore three key areas where we can support you in improving therapy experience

Start therapy with confidence

Choose the right mask for your patients and establish an effective therapy experience from day one.

Focus where it matters

Use digital health solutions to support care by rapidly identifying issues needing priority intervention, and empowering patients to take an active role in their therapy.

Help patients stay engaged

Encourage patients to use self-management tools that provide them with education, motivation, and ongoing support.

Join our Skills Labs at ERS 2026

SKILLS LAB 1
Putting patient experience at the centre of CPAP therapy

Sunday 6 September 10:45 to 11:30, Room 3M (Hall 3)

Chairs: Dr Elisa Perger (IT) and Dr Justine Frija (FR)

  • Redefining success in CPAP therapy: choice of mask as a key driver of patient experience, adherence, and outcomes

Speakers: Dr Maria Mascareno Ponte and Mrs Agnieszka Matthews (UK)

  • Digital health in CPAP: transforming patient engagement into sustained treatment adherence

Speaker: Prof. Chris Carlin (UK)

Add to calendar
09/06/2026 10:45 am 09/06/2026 11:30 am Europe/Paris RESMED SKILLS LAB 1: Putting patient experience at the centre of CPAP therapy RESMED SKILLS LAB 1 Sunday 6 Sept | 10:45 to 11:30, Room 3M (Hall 3)

Putting patient experience at the centre of CPAP therapy
Room 3M (Hall 3) Resmed
SKILLS LAB 2
Engaging patients in therapy: the next step in NIV

Monday 7 September 10:45 to 11:30, Room 3M (Hall 3)

Chairs: Prof. Claudia Crimi (IT) and Dr Maxime Patout (FR)

  • From monitoring to decision-making: the role of digital ecosystems in home NIV therapy

Speaker: Dr Patrick Murphy (UK)

  • Patient engagement in NIV: what can we do to make a difference?

Speaker: Prof. Carla Ribeiro (PT)

Add to calendar
09/07/2026 10:45 am 09/07/2026 11:30 am Europe/Paris RESMED SKILLS LAB 2: Engaging patients in therapy: the next step in NIV RESMED SKILLS LAB 2 Monday 7 Sept | 10:45 to 11:30, Room 3M (Hall 3)

Engaging patients in therapy: the next step in NIV
Room 3M (Hall 3) Resmed

Visit us at Booth J.02

  • Discover how Resmed’s ecosystem of masks, therapy devices, digital solutions and services helps support healthcare professionals across the patient journey, from therapy initiation to long-term follow-up.
  • Explore the latest scientific abstracts and evidence on digital health, personalised sleep care, treatment adherence, and long-term patient outcomes.

Have a question?

Leave your details and one of our team members will be happy to get in touch.

 

Keep exploring

Get it right from the start

Mask choice is a key driver of therapy acceptance and adherence. As a clinician, you can help patients establish a positive therapy experience from day one.

Supporting long-term NIV success

Explore the latest evidence, from landmark clinical trials to real-world studies, to inform patient selection and treatment strategies and support long-term outcomes.

This content is intended for health professionals only.

PROMOTIONAL MATERIAL – CE-marked medical device (CE0123). Manufacturer: Resmed. Local contact: Resmed. Please refer to the instructions for use for relevant information related to any contraindications, warnings and precautions. This content doesn’t constitute medical advice, consult a qualified healthcare professional.

*more than half of these discontinuations were attributable to patient mortality ** depending on patient subgroup

References
  1. Pépin, J.-L.; Bailly, S.; Rinder, P.; Adler, D.; Szeftel, D.; Malhotra, A.; Cistulli, P.A.; Benjafield, A.; Lavergne, F.; Josseran, A.; et al. CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis. J. Clin. Med. 2021, 10, 936. https://doi.org/10.3390/jcm10050936
  2. Pépin JL, Herquelot E, Denis H on behalf of the medXcloud group, et alImpact of long-term non-invasive ventilation on severe exacerbations and survival in COPD: a French nationwide cohort study using multistate modelsThorax 2025;80:616-623.
  3. Bailly, S., Denis, H., Schmidt, A., Pépin, J.-L., Lavergne, F., Malhotra, A., Palot, A., Prigent, A., Benjafield, A., Herquelot, E., Cistulli, P., & Josseran, A. (2025). Health Trajectories around Noninvasive Ventilation Initiation for Obesity Hypoventilation Syndrome. Annals of the American Thoracic Society, 22(10), 1554–1566. https://doi.org/10.1513/AnnalsATS.202411-1160OC

Last updated: 07/2026